Braveheart Bio, Inc. (BRVE) insider trading
Over the last 12 months, 10 insiders bought $159M and 0 insiders sold $0 of Braveheart Bio, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Aug 7, 2026: Andreessen Marc L bought 1,100,000 shares ($19.8M)
- Aug 7, 2026: Orbimed Advisors Llc bought 1,940,000 shares ($34.9M)
- Aug 7, 2026: Chimovits Erez bought 1,940,000 shares ($34.9M)
- Aug 7, 2026: Forbion Growth III Management B.V. bought 3,600,000 shares ($64.8M)
- Aug 7, 2026: Lubner David Charles bought 55,555 shares ($1000K)
- Aug 7, 2026: Murdoch Travis bought 83,333 shares ($1.50M)
- Aug 7, 2026: Anderson Michele A. bought 1,111 shares ($20.0K)
- Aug 7, 2026: Malek David I bought 4,166 shares ($75.0K)
- Aug 7, 2026: Viehbacher Christopher bought 83,333 shares ($1.50M)
- Aug 7, 2026: Rickey James Paul bought 27,777 shares ($500K)